Acer Medical (ROCO:6857) ROCE % : -16.53% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Acer Medical ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Acer Medical's annualized ROCE % for the quarter that ended in Dec. 2023 was -16.53%.

Acer Medical ROCE % Historical Data

The historical data trend for Acer Medical's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acer Medical ROCE % Chart

Acer Medical Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-13.67

-33.88

-28.39

-29.44

-17.08

Acer Medical Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROCE %	Get a 7-Day Free Trial				-34.52	-59.03	-29.67	-17.69	-16.53

Acer Medical ROCE % Calculation

Acer Medical's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-41.16	/	( ( (290.158 - 30.04)	+	(259.427 - 37.49) )	/ 2 )
	=	-41.16	/	( (260.118	+	221.937)	/ 2 )
	=	-41.16	/	241.0275
	=	-17.08 %

Acer Medical's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Jun. 2023 )		(Q: Dec. 2023 )
	=	-38.13	/	( ( (264.537 - 25.076)	+	(259.427 - 37.49) )	/ 2 )
	=	-38.13	/	( ( 239.461	+	221.937 )	/ 2 )
	=	-38.13	/	230.699
	=	-16.53 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

Acer Medical (ROCO:6857) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Acer Medical ROCE % Related Terms

Thank you for viewing the detailed overview of Acer Medical's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Acer Medical (ROCO:6857) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Acer Medical Inc (ROCO:6857) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Xintai 5th Rd, 7th Floor, No. 86, Section 1, Xizhi District, New Taipei, TWN

Website

https://www.acer-medical.com

Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and big data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions into medical institutions.

Acer Medical (ROCO:6857) Headlines

No Headlines